Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer
Clinical trial NCT02581982 · COMPLETED
Trial details
- NCT number
- NCT02581982
- Sponsor
- Wake Forest University Health Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-06
- Primary completion
- 2021-05-11
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.